A Retrospective Study to Evaluate the Safety and Efficacy of a Nucleoside-Sparing Regimen of Darunavir, Ritonavir, and Dolutegravir
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Darunavir (Primary) ; Dolutegravir (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 05 Oct 2017 Planned End Date changed from 31 Jul 2017 to 31 Dec 2017.
- 05 Oct 2017 Planned primary completion date changed from 31 Jul 2017 to 31 Dec 2017.
- 28 Jun 2017 New trial record